Gene · 8767
Papers2,573
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 2,573
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetics Abnormalities with Clinical Impact in Primary Cutaneous Lymphomas. | Cancers (Basel) | 2022 | 36291756 | PubTator, text mining | PubMed |
| M6A RNA Methylation Mediates NOD1/NF-kB Signaling Activation in the Liver of Piglets Challenged with Lipopolysaccharide. | Antioxidants (Basel) | 2022 | 36290677 | PubTator, text mining | PubMed |
| LC3-associated endocytosis and the functions of Rubicon and ATG16L1. | Sci Adv | 2022 | 36288306 | PubTator, text mining | PubMed |
| Applications of covalent chemistry in targeted protein degradation. | Chem Soc Rev | 2022 | 36285735 | PubTator, text mining | PubMed |
| Human ZBP1 induces cell death-independent inflammatory signaling via RIPK3 and RIPK1. | EMBO Rep | 2022 | 36268590 | PubTator, text mining | PubMed |
| Activation of NOD1 and NOD2 in the development of liver injury and cancer. | Front Immunol | 2022 | 36268029 | PubTator, text mining | PubMed |
Comprehensive single cell analysis of pandemic influenza A virus infection in the human airways uncovers cell-type specific host transcriptional signatures relevant for disease progression and pathogenesis. | Front Immunol | 2022 | 36268025 | PubTator, text mining | PubMed |
| Oral supplementation with selected Lactobacillus acidophilus triggers IL-17-dependent innate defense response, activation of innate lymphoid cells type 3 and improves colitis. | Sci Rep | 2022 | 36266398 | PubTator, text mining | PubMed |
| Comparative and evolutionary analysis of RIP kinases in immune responses. | Front Genet | 2022 | 36263437 | PubTator, text mining | PubMed |
| Emerging Role of Dendritic Cell Intervention in the Treatment of Inflammatory Bowel Disease. | Biomed Res Int | 2022 | 36262975 | PubTator, text mining | PubMed |
| NOD1 and NOD2 Are Potential Therapeutic Targets for Cancer Immunotherapy. | Comput Intell Neurosci | 2022 | 36262606 | PubTator, text mining | PubMed |
| Turning up the heat on non-immunoreactive tumors: autophagy influences the immune microenvironment in pancreatic cancer. | BMC Med Genomics | 2022 | 36261830 | PubTator, text mining | PubMed |
| RIPK3 modulates sarcoma through immune checkpoint HAVCR2. | Oncol Lett | 2022 | 36238358 | PubTator, text mining | PubMed |
| Muramyl dipeptide-based analogs as potential anticancer compounds: Strategies to improve selectivity, biocompatibility, and efficiency. | Front Oncol | 2022 | 36237313 | PubTator, text mining | PubMed |
| Discovery of E3 Ligase Ligands for Target Protein Degradation. | Molecules | 2022 | 36235052 | PubTator, text mining | PubMed |
| Biomarkers of Periodontitis and Its Differential DNA Methylation and Gene Expression in Immune Cells: A Systematic Review. | Int J Mol Sci | 2022 | 36233348 | PubTator, text mining | PubMed |
| Loss of non-motor kinesin KIF26A causes congenital brain malformations via dysregulated neuronal migration and axonal growth as well as apoptosis. | Dev Cell | 2022 | 36228617 | PubTator, text mining | PubMed |
| The regulation and potential roles of m6A modifications in early embryonic development and immune tolerance at the maternal-fetal interface. | Front Immunol | 2022 | 36225914 | PubTator, text mining | PubMed |
| Selective autophagy of RIPosomes maintains innate immune homeostasis during bacterial infection. | EMBO J | 2022 | 36221902 | Swiss-Prot, curated | PubMed |
| Exosomes: mediators regulating the phenotypic transition of vascular smooth muscle cells in atherosclerosis. | Cell Commun Signal | 2022 | 36221105 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8767/papers?page=21